Characterization of a recombinant Onchocerca volvulus antigen (Ov33) produced in yeast

American Journal of Tropical Medicine and Hygiene

Volumn 57, Issue 5, 1997, Pages 626-633

  Tume, C B ^a   Ngu, J L ^a   McKerrow, J L ^b   Seigel, J ^b   Sun, E ^b   Barr, P J ^c,d   Bathurst, I ^c,d   Morgan, G ^e   Nkenfou, C ^a   Asonganyi, T ^a   Lando, G ^a  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d LXR Biotechnology   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN OV 33; ASPARTIC PROTEINASE INHIBITOR; PARASITE ANTIGEN; PEPSIN A; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEUKOCYTE ADHERENCE; MAJOR CLINICAL STUDY; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; SACCHAROMYCES CEREVISIAE; SERODIAGNOSIS;

ANIMALS; ANTIGENS, HELMINTH; CELL ADHESION; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MICE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; RABBITS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY;

EID: 0030696496     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lymphatic Filariasis and Onchocerciasis, 1993. Tropical Disease Research Progress 1991-92. Eleventh Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: World Health Organization.
2. Donelson JE, Duke BO, Moser D, Zeng WL, Erondu NE, Lucius R, Renz A, Karam M, Flores GZ, 1988. Construction of Onchocerca volvulus cDNA libraries and partial characterization of the cDNA for a major antigen. Mol Biochem Parasitol 31: 241-250.
3. Barr PJ, Gibson HL, Bathurst IC, Sabin EA, Medina-Selby A. Coit D, Valenzuela P. 1989. Recombinant subunit vaccines from yeast. Barr PJ, Brake AJ, Valenzuela P eds. Yeast Genetic Engineering. New York: Butterworths, 319-339.
4. Young RA, Davis RW, 1983. Yeast RNA polymerase II genes: isolation with antibody probes. Science 222: 778-782.
5. Gussow D, Clackson T, 1989. Direct clone characterization from plaques and colonies by the polymerase chain reaction. Nucleic Acids Res 17: 4000.
6. Sanger F, Nicklen S, Coulson AR, 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467.
7. Lucius R, Erondu N, Kern A, Donelson JE, 1988. Molecular cloning of an immunodominant antigen of Onchocerca volvulus. J Exp Med 168: 1199-1204.
8. Barr PJ, Gibson HL, Enea V, Arnot DE, Hollingdale MR, Nussenzweig V, 1987. Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine. J Exp Med 165: 1160-1171.
9. Laemmli UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
10. Towbin H, Staehelin T, Gordon J, 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
11. McKerrow JH, Jeong KH, Beckstead JH, 1985. Enzyme histochemical comparison of Biomphalaria glabrata amebocytes with human granuloma macrophages. J Leukoc Biol 37: 341-347.
12. Martzen MR, McMuIlen BA, Smith NE, Fujikawa K, Peanasky RJ 1990. Primary structure of the major pepsin inhibitor from the intestinal parasite nematode, Ascaris suum. Biochemistry 29: 7366-7372.
13. Chandrashekar R, Masood A, Alvarez RM, Ogunrinade AF, Lujan R, Richards FO Jr, Weil GJ, 1991. Molecular cloning and characterization of recombinant parasite antigens for immunodiagnosis of onchocerciasis. J Clin Invest 88: 1460-1466.